OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pharmacogenomic aspects of bipolar disorder: An update
Monika Budde, Detlef Degner, Jürgen Brockmöller, et al.
European Neuropsychopharmacology (2017) Vol. 27, Iss. 6, pp. 599-609
Open Access | Times Cited: 31
Monika Budde, Detlef Degner, Jürgen Brockmöller, et al.
European Neuropsychopharmacology (2017) Vol. 27, Iss. 6, pp. 599-609
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Bipolar disorders
Eduard Vieta, Michael Berk, Thomas G. Schulze, et al.
Nature Reviews Disease Primers (2018) Vol. 4, Iss. 1
Closed Access | Times Cited: 644
Eduard Vieta, Michael Berk, Thomas G. Schulze, et al.
Nature Reviews Disease Primers (2018) Vol. 4, Iss. 1
Closed Access | Times Cited: 644
Pharmacogenetics in Psychiatry
Filippo Corponi, Chiara Fabbri, Alessandro Serretti
Advances in pharmacology (2018), pp. 297-331
Closed Access | Times Cited: 42
Filippo Corponi, Chiara Fabbri, Alessandro Serretti
Advances in pharmacology (2018), pp. 297-331
Closed Access | Times Cited: 42
The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine
Claudia Pisanu, Urs Heilbronner, Alessio Squassina
Molecular Diagnosis & Therapy (2018) Vol. 22, Iss. 4, pp. 409-420
Closed Access | Times Cited: 41
Claudia Pisanu, Urs Heilbronner, Alessio Squassina
Molecular Diagnosis & Therapy (2018) Vol. 22, Iss. 4, pp. 409-420
Closed Access | Times Cited: 41
Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters
Teresa Iannaccone, Carmine Sellitto, Valentina Manzo, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 204-204
Open Access | Times Cited: 30
Teresa Iannaccone, Carmine Sellitto, Valentina Manzo, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 204-204
Open Access | Times Cited: 30
Whole Genome Expression Analyses of miRNAs and mRNAs Suggest the Involvement of miR-320a and miR-155-3p and their Targeted Genes in Lithium Response in Bipolar Disorder
Claudia Pisanu, Eleni Merkouri Papadima, Carla Melis, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6040-6040
Open Access | Times Cited: 35
Claudia Pisanu, Eleni Merkouri Papadima, Carla Melis, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 6040-6040
Open Access | Times Cited: 35
Chronic Lithium Treatment Affects Anxious Behaviors and theExpression of Serotonergic Genes in Midbrain Raphe Nuclei of Defeated Male Mice
Dmitry A. Smagin, И. Л. Коваленко, Anna G. Galyamina, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1293-1293
Open Access | Times Cited: 21
Dmitry A. Smagin, И. Л. Коваленко, Anna G. Galyamina, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1293-1293
Open Access | Times Cited: 21
Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disorders
Аnastasia Levchenko, Timur Nurgaliev, Alexander Kanapin, et al.
Heliyon (2020) Vol. 6, Iss. 5, pp. e03990-e03990
Open Access | Times Cited: 22
Аnastasia Levchenko, Timur Nurgaliev, Alexander Kanapin, et al.
Heliyon (2020) Vol. 6, Iss. 5, pp. e03990-e03990
Open Access | Times Cited: 22
Personalized and precision medicine as informants for treatment management of bipolar disorder
Giulio Perugi, Pietro De Rossi, Andrea Fagiolini, et al.
International Clinical Psychopharmacology (2019) Vol. 34, Iss. 4, pp. 189-205
Closed Access | Times Cited: 20
Giulio Perugi, Pietro De Rossi, Andrea Fagiolini, et al.
International Clinical Psychopharmacology (2019) Vol. 34, Iss. 4, pp. 189-205
Closed Access | Times Cited: 20
The Genetics of Response to and Side Effects of Lithium Treatment in Bipolar Disorder: Future Research Perspectives
Fanny Senner, Mojtaba Oraki Kohshour, Safa I.A. Abdalla, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 16
Fanny Senner, Mojtaba Oraki Kohshour, Safa I.A. Abdalla, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 16
Divergent Directionality of Immune Cell-Specific Protein Expression between Bipolar Lithium Responders and Non-Responders Revealed by Enhanced Flow Cytometry
Keming Gao, Nicholas M. Kaye, Marzieh Ayati, et al.
Medicina (2023) Vol. 59, Iss. 1, pp. 120-120
Open Access | Times Cited: 6
Keming Gao, Nicholas M. Kaye, Marzieh Ayati, et al.
Medicina (2023) Vol. 59, Iss. 1, pp. 120-120
Open Access | Times Cited: 6
Genetics of Lithium Response in Bipolar Disorder
Sergi Papiol, Thomas G. Schulze, Martin Alda
Pharmacopsychiatry (2018) Vol. 51, Iss. 05, pp. 206-211
Closed Access | Times Cited: 17
Sergi Papiol, Thomas G. Schulze, Martin Alda
Pharmacopsychiatry (2018) Vol. 51, Iss. 05, pp. 206-211
Closed Access | Times Cited: 17
Effects of chronic lithium treatment on anxious behaviors and serotonergic genes expression in the midbrain raphe nuclei in defeated male mice
Dmitry A. Smagin, И. Л. Коваленко, Anna G. Galyamina, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 13
Dmitry A. Smagin, И. Л. Коваленко, Anna G. Galyamina, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 13
Genetische Grundlagen der bipolaren Störung
Monika Budde, Andreas J. Forstner, Kristina Adorjan, et al.
Der Nervenarzt (2017) Vol. 88, Iss. 7, pp. 755-759
Closed Access | Times Cited: 16
Monika Budde, Andreas J. Forstner, Kristina Adorjan, et al.
Der Nervenarzt (2017) Vol. 88, Iss. 7, pp. 755-759
Closed Access | Times Cited: 16
Transcriptomics and miRNomics data integration in lymphoblastoid cells highlights the key role of immune-related functions in lithium treatment response in Bipolar disorder
Nadia Cattane, Cindie Courtin, Elisa Mombelli, et al.
BMC Psychiatry (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Nadia Cattane, Cindie Courtin, Elisa Mombelli, et al.
BMC Psychiatry (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Recent Trends on the Role of Epigenomics, Metabolomics and Noncoding RNAs in Rationalizing Mood Stabilizing Treatment
Claudia Pisanu, Θεοδώρα Κάτσιλα, George P. Patrinos, et al.
Pharmacogenomics (2017) Vol. 19, Iss. 2, pp. 129-143
Closed Access | Times Cited: 11
Claudia Pisanu, Θεοδώρα Κάτσιλα, George P. Patrinos, et al.
Pharmacogenomics (2017) Vol. 19, Iss. 2, pp. 129-143
Closed Access | Times Cited: 11
Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection
Alfredo B. Cuéllar‐Barboza, Susan L. McElroy, Marin Veldić, et al.
International Journal of Bipolar Disorders (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 11
Alfredo B. Cuéllar‐Barboza, Susan L. McElroy, Marin Veldić, et al.
International Journal of Bipolar Disorders (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 11
Mini review: Recent advances on epigenetic effects of lithium
Cynthia Marie‐Claire, Bruno Étain, Frank Bellivier
Neuroscience Letters (2021) Vol. 761, pp. 136116-136116
Open Access | Times Cited: 10
Cynthia Marie‐Claire, Bruno Étain, Frank Bellivier
Neuroscience Letters (2021) Vol. 761, pp. 136116-136116
Open Access | Times Cited: 10
SCN11A mRNA levels in female bipolar disorder PBMCs as tentative biomarker for distinct patient sub‐phenotypes
Irena Voinsky, Michael J. McCarthy, Tatyana Shekhtman, et al.
Drug Development Research (2019) Vol. 80, Iss. 8, pp. 1128-1135
Closed Access | Times Cited: 5
Irena Voinsky, Michael J. McCarthy, Tatyana Shekhtman, et al.
Drug Development Research (2019) Vol. 80, Iss. 8, pp. 1128-1135
Closed Access | Times Cited: 5
Predicted Cellular and Molecular Actions of Lithium in the Treatment of Bipolar Disorder: An In Silico Study
Hadi Najafi, Mehdi Totonchi, Majid Sadeghizadeh
CNS Drugs (2020) Vol. 34, Iss. 5, pp. 521-533
Closed Access | Times Cited: 4
Hadi Najafi, Mehdi Totonchi, Majid Sadeghizadeh
CNS Drugs (2020) Vol. 34, Iss. 5, pp. 521-533
Closed Access | Times Cited: 4
Personalized treatment in bipolar disorder
Estela Salagre, Eduard Vieta, Iría Grande
Elsevier eBooks (2019), pp. 423-436
Closed Access | Times Cited: 3
Estela Salagre, Eduard Vieta, Iría Grande
Elsevier eBooks (2019), pp. 423-436
Closed Access | Times Cited: 3
How Useful Are Pharmacogenomic Decision Support Tools for the Treatment of Bipolar Disorder?
Jeffrey J. Rakofsky
FOCUS The Journal of Lifelong Learning in Psychiatry (2018) Vol. 16, Iss. 2, pp. 177-178
Open Access | Times Cited: 1
Jeffrey J. Rakofsky
FOCUS The Journal of Lifelong Learning in Psychiatry (2018) Vol. 16, Iss. 2, pp. 177-178
Open Access | Times Cited: 1
The mechanisms of action of lithium in bipolar disorder
Keming Gao, Joseph R. Calabrese
Elsevier eBooks (2020), pp. 357-364
Closed Access | Times Cited: 1
Keming Gao, Joseph R. Calabrese
Elsevier eBooks (2020), pp. 357-364
Closed Access | Times Cited: 1
Genetics of bipolar disorder
Kevin S. O’Connell, Olav B. Smeland, Ole A. Andreassen
Elsevier eBooks (2022), pp. 43-61
Closed Access | Times Cited: 1
Kevin S. O’Connell, Olav B. Smeland, Ole A. Andreassen
Elsevier eBooks (2022), pp. 43-61
Closed Access | Times Cited: 1
Update on Research into the Genetics and Pharmacogenetics of Bipolar Disorder
Thomas G. Schulze
Dusunen Adam The Journal of Psychiatry and Neurological Sciences (2017)
Open Access
Thomas G. Schulze
Dusunen Adam The Journal of Psychiatry and Neurological Sciences (2017)
Open Access
Bipolar Disorder in Primary Care: Considerations in Management
Hilja Ruegg, Suzanne Watson, Melissa P. DelBello, et al.
Current Treatment Options in Psychiatry (2018) Vol. 5, Iss. 4, pp. 441-451
Closed Access
Hilja Ruegg, Suzanne Watson, Melissa P. DelBello, et al.
Current Treatment Options in Psychiatry (2018) Vol. 5, Iss. 4, pp. 441-451
Closed Access
